Cereblon ligands and difunctional compounds containing cereblon ligands
JP2026097868APending Publication Date: 2026-06-16ARVINAS OPERATIONS INC
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- ARVINAS OPERATIONS INC
- Filing Date
- 2026-02-19
- Publication Date
- 2026-06-16
Smart Images

Figure 2026097868000001_ABST
Abstract
This provides compounds useful as inhibitors of various polypeptides and other proteins. [Solution] The present invention provides cereblon E3 ligase-binding compounds, including bifunctional compounds containing cereblon E3 ligase-binding compounds, which have been found to be useful as regulators of targeted ubiquitination, and in particular as inhibitors of various polypeptides and other proteins that are degraded by and / or inhibited by other means by the bifunctional compounds according to this disclosure. In particular, this specification provides compounds that contain a ligand that binds to E3 ubiquitin ligase on one end and a portion that binds to a target protein on the other end, thereby positioning the target protein in close proximity to the ubiquitin ligase and causing degradation (and inhibition) of the protein.
Need to check novelty before this filing date? Find Prior Art